- SLRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Salarius Pharmaceuticals (SLRX) S-3Shelf registration
Filed: 18 Mar 16, 12:00am
Period from February 26, 2014 (Inception) to December 31, 2014 | Year ended December 31, 2015 | |||||||
Earnings: | ||||||||
Pretax loss | $ | (8,010,860 | ) | $ | (29,141,630 | ) | ||
Add fixed charges | 45,600 | 75,900 | ||||||
Total earnings | (7,965,260 | ) | (29,065,730 | ) | ||||
Fixed charges: | ||||||||
Interest expense, including amortization of debt issuance costs | — | — | ||||||
Estimated interest component of rent expense (a) | 45,600 | 75,900 | ||||||
Total fixed charges | 45,600 | 75,900 | ||||||
Preference security dividends | — | — | ||||||
Ratio of earnings to combined fixed charges and preference dividends | (b) | (b) | ||||||
Deficiency of earnings available to cover combination of fixed charges and preference dividends | $ | (8,010,860 | ) | $ | (29,141,630 | ) |